Free Trial

Guardian Pharmacy Services (NYSE:GRDN) Shares Gap Down - Time to Sell?

Guardian Pharmacy Services logo with Medical background

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $26.50, but opened at $24.20. Guardian Pharmacy Services shares last traded at $22.01, with a volume of 16,142 shares traded.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on GRDN. Raymond James set a $28.00 price objective on shares of Guardian Pharmacy Services and gave the company an "outperform" rating in a research note on Wednesday, May 14th. Truist Financial reissued a "buy" rating and set a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday.

Check Out Our Latest Stock Report on Guardian Pharmacy Services

Guardian Pharmacy Services Price Performance

The firm has a 50-day simple moving average of $23.02 and a two-hundred day simple moving average of $21.93.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last issued its quarterly earnings data on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to the consensus estimate of $321.21 million. Equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Large investors have recently modified their holdings of the company. Brown Advisory Inc. grew its position in shares of Guardian Pharmacy Services by 0.6% in the 1st quarter. Brown Advisory Inc. now owns 1,602,824 shares of the company's stock worth $34,076,000 after acquiring an additional 8,870 shares in the last quarter. J. Goldman & Co LP lifted its stake in shares of Guardian Pharmacy Services by 1.5% in the 4th quarter. J. Goldman & Co LP now owns 762,347 shares of the company's stock worth $15,445,000 after acquiring an additional 11,263 shares during the period. Nuveen Asset Management LLC lifted its stake in Guardian Pharmacy Services by 2.9% during the fourth quarter. Nuveen Asset Management LLC now owns 547,140 shares of the company's stock valued at $11,085,000 after purchasing an additional 15,550 shares during the last quarter. Franklin Resources Inc. lifted its stake in Guardian Pharmacy Services by 2.6% during the fourth quarter. Franklin Resources Inc. now owns 513,029 shares of the company's stock valued at $10,394,000 after purchasing an additional 13,029 shares during the last quarter. Finally, Wellington Management Group LLP lifted its stake in Guardian Pharmacy Services by 14.2% during the first quarter. Wellington Management Group LLP now owns 464,924 shares of the company's stock valued at $9,884,000 after purchasing an additional 57,924 shares during the last quarter.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines